首站-论文投稿智能助手
典型文献
Endothelial PDGF-BB/PDGFR-βsignaling promotes osteoarthritis by enhancing angiogenesis-dependent abnormal subchondral bone formation
文献摘要:
INTRODUCTION Osteoarthritis (OA) is a highly prevalent and degenerative joint disease that leads to chronic pain and physical disability, resulting in a major financial and clinical burden.
文献关键词:
作者姓名:
Zhuang Cui;Hangtian Wu;Ye Xiao;Ting Xu;Junjie Jia;Hancheng Lin;Rongmin Lin;Kun Chen;Yihuang Lin;Kaiqun Li;Xiaohu Wu;Changjun Li;Bin Yu
作者机构:
Division of Orthopaedics and Traumatology,Department of Orthopaedics,Nanfang Hospital,Southern Medical University,Guangzhou,Guangdong,China;Guangdong Provincial Key Laboratory of Bone and Cartilage Regeneration Medicine,Nanfang Hospital,Southern Medical University,Guangzhou,Guangdong,China;Department of Endocrinology,Endocrinology Research Center,Xiangya Hospital of Central South University,Changsha,Hunan 410008,China;National Clinical Research Center for Geriatric Disorders,Xiangya Hospital,Changsha,Hunan 410008,China;Department of Sleep Medicine Center,Nanfang Hospital,Southern Medical University,Guangzhou,Guangdong 510515,China
引用格式:
[1]Zhuang Cui;Hangtian Wu;Ye Xiao;Ting Xu;Junjie Jia;Hancheng Lin;Rongmin Lin;Kun Chen;Yihuang Lin;Kaiqun Li;Xiaohu Wu;Changjun Li;Bin Yu-.Endothelial PDGF-BB/PDGFR-βsignaling promotes osteoarthritis by enhancing angiogenesis-dependent abnormal subchondral bone formation)[J].骨研究(英文版),2022(04):852-866
A类:
Osteoarthritis
B类:
Endothelial,BB,PDGFR,signaling,promotes,osteoarthritis,by,enhancing,angiogenesis,dependent,abnormal,subchondral,bone,formation,INTRODUCTION,OA,highly,prevalent,degenerative,joint,disease,that,leads,chronic,pain,physical,disability,resulting,major,financial,clinical,burden
AB值:
0.847696
相似文献
PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells
Wei Tang;Yu Wu;Xin Qi;Rilei Yu;Zhimin Lu;Ao Chen;Xinglong Fan;Jing Li-Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China;Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease of the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China;Department of Thoracic Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao 266003, China;Open Studio for Druggability Research of Marine Natural Products, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao 266003, China;Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266003, China
Recent developments of neuroprotective agents for degenerative retinal disorders
Kepeng Ou;Youjian Li;Ling Liu;Hua Li;Katherine Cox;Jiahui Wu;Jian Liu;Andrew D.Dick-College of Pharmacy,National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics,IATTI,Chongqing University of Arts and Sciences,Chongqing,China;Translational Health Sciences,Bristol Medical School,University of Bristol,Bristol,UK;Department of Ophthalmology,Yongchuan Hospital,Chongqing Medical University,Chongqing,China;Department of Ophthalmology,Shanghai General Hospital (Shanghai First People's Hospital),Shanghai Jiao Tong University School of Medicine,Shanghai,China;Institute of Ophthalmology,University College London,London,UK;National Institute for Health Research Biomedical Research Centre,Moorfields Eye Hospital,London,UK
Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis
Hong-Guang Zhang;Bin Wang;Yong Yang;Xuan Liu;Junjie Wang;Ning Xin;Shifeng Li;Ying Miao;Qiuyu Wu;Tingting Guo;Yukang Yuan;Yibo Zuo;Xiangjie Chen;Tengfei Ren;Chunsheng Dong;Jun Wang;Hang Ruan;Miao Sun;Xingshun Xu;Hui Zheng-International Institute of Infection and Immunity,Institutes of Biology and Medical Sciences,Soochow University,Suzhou,Jiangsu,China;Jiangsu Key Laboratory of Infection and Immunity,Soochow University,Suzhou,Jiangsu,China;Institute of Neuroscience,Soochow University,Suzhou,Jiangsu,China;Institute for Fetology,the First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China;Department of Psychiatry,the Affiliated Guangji Hospital of Soochow University,Suzhou,Jiangsu,China;Department of Neurology,the First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China;Department of Intensive Care Medicine,the First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China;Jiangsu Key Laboratory of Neuropsychiatric Diseases,Soochow University,Suzhou,Jiangsu,China
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis
Fang Wang;Jia-nan Wang;Xiao-yan He;Xiao-guo Suo;Chao Li;Wei-jian Ni;Yu-ting Cai;Yuan He;Xin-yun Fang;Yu-hang Dong;Tian Xing;Ya-ru Yang;Feng Zhang;Xiang Zhong;Hong-mei Zang;Ming-ming Liu;Jun Li;Xiao-ming Meng;Juan Jin-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Anhui Institute of Innovative Drugs,School of Pharmacy,Anhui Medical University,The Key Laboratory of Anti-inflammatory of Immune Medicines,Ministry of Education,Hefei 230032,China;Department of Pharmacy,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China;Hospital of Stomatology,Anhui Medical University,Key Laboratory of Oral Diseases Research of Anhui Province,Hefei 230032,China;Department of Pharmacy,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Nephrology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China;School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
Ying Dong;Bi-xi Tang;Qi Wang;Li-wei Zhou;Cong Li;Xuan Zhang;Dan-dan Sun;Xin Sun;Xue-mei Zhang;Bing Xiong;Jia Li;Hong Shi;Dan-qi Chen;Yi Zang-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology,School of Pharmacy,Fudan University,Shanghai 201203,China;Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Center for Supramolecular Chemistry and Catalysis and Department of Chemistry,College of Sciences,Shanghai University,Shanghai 200444,China;Schoolof Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210023,China;Schoolof Pharmacy,Henan University,Kaifeng 475004,China;Open Studio for Druggability Research of Marine Natural Products,Pilot National Laboratory for Marine Science and Technology(Qingdao),Qingdao 266237,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou 310024,China;Department of Anesthesiology of Shanghai Pulmonary Hospital,School of medicine,Tongji University,Shanghai 200433,China
CDDO-Im ameliorates osteoarthritis and inhibits chondrocyte apoptosis in mice via enhancing Nrf2-dependent autophagy
Jian Dong;Kai-jia Zhang;Gao-cai Li;Xing-ren Chen;Jia-jia Lin;Jia-wei Li;Zhong-yang Lv;Zhao-zhi Deng;Jin Dai;Wangsen Cao;Qing Jiang-Division of Sports Medicine and Adult Reconstructive Surgery,Department of Orthopedic Surgery,State Key Laboratory of Pharmaceutical Biotechnology,Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China;Department of Orthopedics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Critical Care Medicine,Jinling Hospital,School of Medicine,Nanjing University Medical School,Nanjing 210003,China;Center for Organ Fibrosis and Remodeling Research,Jiangsu Key Lab of Molecular Medicine,Nanjing University Medical School,Nanjing 210093,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。